ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $73,000 | -64.7% | 37,000 | -65.8% | 0.00% | -100.0% |
Q3 2015 | $207,000 | -43.6% | 108,300 | +36.7% | 0.00% | 0.0% |
Q2 2015 | $367,000 | +20.3% | 79,200 | +13.5% | 0.00% | 0.0% |
Q1 2015 | $305,000 | -81.8% | 69,800 | -85.5% | 0.00% | -80.0% |
Q4 2014 | $1,674,000 | -4.8% | 482,500 | +14.9% | 0.01% | -16.7% |
Q3 2014 | $1,759,000 | +222.2% | 419,800 | +350.4% | 0.01% | +200.0% |
Q2 2014 | $546,000 | – | 93,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |